Your search for ‘Knights’ returned 217 results

In what has been one of the most litigated and acrimonious takeover bids of the past year, the Bureau de décision et de révision (Québec) (the "Bureau") exercised its public interest discretionary power to cease trade the issuance of shares by Fibrek Inc. ("Fibrek") to a "white knight".

As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust enforcement environment they are likely to face in 2025.